Fidelity Investments’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
ACM
TGA
PBPIA
NCM
AC
RC
Fidelity Investments's RLYB Position: Q2 2026 in Review
Fidelity Investments increased its Rallybio (RLYB) stake by 0.16% in Q2 2026, buying an estimated $16.3K and bringing the position to 794,720 shares worth $12.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2041.
Fidelity Investments first reported a position in RLYB in Q3 2021 and has held it in 20 quarters since. The position peaked at $50.8M in Q3 2021. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.
- Fidelity Investments held 794,720 shares of Rallybio worth $12.7M as of Q2 2026.
- Fidelity Investments bought 1,269 Rallybio shares in Q2 2026, an estimated $16.3K.
- Rallybio made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2041 holding.
- Fidelity Investments first reported a position in Rallybio in Q3 2021 and has held it in 20 quarters since.
- Fidelity Investments's Rallybio position peaked at $50.8M in Q3 2021.
- 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.